Range Low Price High Price Comment
30 days $142.01 $161.00 Wednesday, 27th Mar 2024 ASND stock ended at $148.44. This is 1.01% less than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 2.53% from a day low at $146.93 to a day high of $150.65.
90 days $119.03 $161.00
52 weeks $64.33 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2023-09-27 $94.74 $95.32 $92.69 $94.07 194 940
2023-09-26 $95.69 $96.54 $94.00 $94.21 330 553
2023-09-25 $94.41 $96.68 $93.01 $95.50 178 771
2023-09-22 $96.20 $97.11 $94.58 $95.06 307 549
2023-09-20 $98.09 $99.47 $95.58 $95.60 178 476
2023-09-19 $101.69 $102.55 $97.20 $98.09 305 685
2023-09-18 $102.66 $103.37 $100.23 $102.04 225 880
2023-09-15 $103.39 $104.24 $101.45 $102.66 177 573
2023-09-14 $100.78 $103.87 $100.20 $103.39 544 951
2023-09-13 $102.95 $104.05 $99.52 $100.23 299 965
2023-09-12 $99.83 $103.01 $98.65 $102.56 387 162
2023-09-11 $97.39 $101.37 $96.56 $100.06 441 651
2023-09-08 $103.40 $104.19 $97.05 $97.58 506 651
2023-09-07 $102.56 $104.06 $100.96 $103.10 413 693
2023-09-06 $103.42 $106.45 $100.02 $103.97 837 325
2023-09-05 $97.37 $99.81 $95.56 $99.74 431 379
2023-09-01 $99.09 $99.30 $97.47 $98.27 107 818
2023-08-31 $96.33 $98.88 $95.69 $98.02 143 420
2023-08-30 $99.71 $100.57 $96.42 $96.56 233 523
2023-08-29 $98.47 $101.56 $98.09 $99.92 231 730
2023-08-28 $98.92 $98.99 $97.53 $98.47 193 538
2023-08-25 $95.28 $99.98 $95.08 $98.91 295 156
2023-08-24 $94.41 $96.13 $92.89 $95.87 269 393
2023-08-23 $92.51 $95.98 $92.51 $93.99 210 232
2023-08-22 $93.91 $95.07 $91.49 $92.51 165 936
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT